These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38226116)

  • 21. A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis.
    Heikal MA; Soliman TT; Abousaif WS; Shebl AA
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):353-361. PubMed ID: 34453603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vernal Keratoconjunctivitis: A Systematic Review.
    Bruschi G; Ghiglioni DG; Cozzi L; Osnaghi S; Viola F; Marchisio P
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):277-329. PubMed ID: 37658939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
    Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
    Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children.
    Liendo VL; Vola ME; Barreiro TP; Wakamatsu TH; Gomes JÁP; Santos MSD
    Arq Bras Oftalmol; 2017; 80(4):211-214. PubMed ID: 28954018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
    Vichyanond P; Kosrirukvongs P
    Curr Allergy Asthma Rep; 2013 Jun; 13(3):308-14. PubMed ID: 23625179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term use of topical tacrolimus ointment: a safe and effective option for the treatment of vernal keratoconjunctivitis.
    Müller GG; José NK; de Castro RS; de Holanda EC
    Arq Bras Oftalmol; 2019; 82(2):119-123. PubMed ID: 30698232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of vernal keratoconjunctivitis.
    Leonardi A
    Ophthalmol Ther; 2013 Dec; 2(2):73-88. PubMed ID: 25135808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
    Chatterjee S; Agrawal D
    Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Safety and Efficacy of Tacrolimus 0.1% in Severe Pediatric Vernal Keratoconjunctivitis.
    Caputo R; Marziali E; de Libero C; Di Grande L; Danti G; Virgili G; Villani E; Mori F; Bacci GM; Lucenteforte E; Pucci N
    Cornea; 2021 Nov; 40(11):1395-1401. PubMed ID: 34029239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis.
    Al-Amri AM; Fiorentini SF; Albarry MA; Bamahfouz AY
    Oman J Ophthalmol; 2017; 10(3):145-149. PubMed ID: 29118487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q; Tang J; Han Y; Wang D; Ye H
    Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of single dose dermatological 0.1% Tacrolimus Ointment in the treatment of vernal keratoconjunctivitis.
    Sharjeel M; Iqbal U; Jabran A; Mehmood A; Mohiuddin M
    J Pak Med Assoc; 2022 Sep; 72(9):1694-1698. PubMed ID: 36280958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood chronic anterior uveitis associated with vernal keratoconjunctivitis (VKC): successful treatment with topical tacrolimus. Case series.
    Taddio A; Cimaz R; Caputo R; de Libero C; Di Grande L; Simonini G; Mori F; Novembre E; Pucci N
    Pediatr Rheumatol Online J; 2011 Nov; 9(1):34. PubMed ID: 22047067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.
    Miyazaki D; Tominaga T; Kakimaru-Hasegawa A; Nagata Y; Hasegawa J; Inoue Y
    Ophthalmology; 2008 Jun; 115(6):988-992.e5. PubMed ID: 17900694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis.
    Shoji J; Ohashi Y; Fukushima A; Miyazaki D; Uchio E; Takamura E; Fujishima H; Namba K; Kumagai N; Ebihara N; Okamoto S
    Curr Eye Res; 2019 Jul; 44(7):796-805. PubMed ID: 30947551
    [No Abstract]   [Full Text] [Related]  

  • 39. Treating refractory corneal hydrops in a male patient with vernal keratoconjunctivitis and mental retardation: a case report.
    Shih EJ; Lin JC; Peng KL; Chen JL
    BMC Ophthalmol; 2022 Jan; 22(1):36. PubMed ID: 35073856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vernal Keratoconjunctivitis in Kashmir: A temperate zone.
    Sofi RA; Mufti A
    Int Ophthalmol; 2016 Dec; 36(6):875-879. PubMed ID: 26961753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.